Rothschild Investment »

Aardvark Therapeutics shares owned by Rothschild Investment

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Rothschild Investment from 13F filings

Historical chart of Rothschild Investment investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Rothschild Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Rothschild Investment

Quarter filed Position value Share count Share price at filing
2026-03-31 $289 77 3.77

More positions owned by Rothschild Investment

Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Invesco Rafi Us 1000 Etf Etf (PRF)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Amazon Stock (AMZN)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Exxon Mobil Corp Stock (XOM)
Johnson & Johnson Stock (JNJ)
Capital Group Dividend Growers Etf Etf (CGDG)
Blackstone Stock (BX)
Abbvie Stock (ABBV)
Chevron Corporation Stock (CVX)

View all positions for Rothschild Investment

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
BlackRock
Vanguard Group
Vanguard Capital Management
Polygon Management
Geode Capital Management
Silverarc Capital Management
Two Sigma Investments
State Street Corporation
UBS Group
AQR Capital Management
Millennium Management
Northern Trust

View all funds holding Aardvark Therapeutics